Related Experiment Video
Updated: Jul 27, 2026
Biolistic Transformation of a Fluorescent Tagged Gene into the Opportunistic Fungal Pathogen Cryptococcus neoformans
Published on: March 19, 2015
Identification of virulence mutants of the fungal pathogen Cryptococcus neoformans using signature-tagged mutagenesis
1Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, Missouri 63104, USA.
Abstract:
Cryptococcus neoformans var. neoformans is an important opportunistic fungal pathogen of patients whose immune system has been compromised due to viral infection, antineoplastic chemotherapy, or tissue transplantation. As many as 13% of all AIDS patients suffer a life-threatening cryptococcal infection at some time during the course of their HIV disease. To begin to understand the molecular basis for virulence in Cryptococcus neoformans var. neoformans serotype A, we have employed signature-tagged mutagenesis (STM) to identify mutants with altered virulence in a mouse model. The critical parameters of signature-tagged mutagenesis in C. neoformans are explored. Data are presented showing that at least 100 different strains can be mixed together in a single animal with each participating in the infection and that there is no apparent interaction between a virulent strain and an avirulent strain in our animal model. Using signature-tagged mutagenesis, we identified 39 mutants with significantly altered growth in a competitive assay. Molecular analyses of these mutants indicated that 19 (49%) contained an insertion in the actin promoter by homologous recombination from a single crossover event, creating a duplication of the actin promoter and the integration of single or multiple copies of the vector. Analysis of the chromosomal insertion sites of those mutants that did not have an integration event in the actin promoter revealed an approximately random distribution among the chromosomes. Individual challenge of the putative mutants in a mouse model revealed five hypovirulent mutants and one hypervirulent mutant.
Insights
This study used signature-tagged mutagenesis to identify Cryptococcus neoformans mutants with altered virulence. Researchers found five hypovirulent and one hypervirulent mutant, advancing understanding of fungal pathogen mechanisms.
Area of Science:
- Mycology
- Infectious Diseases
- Genetics
Background:
- Cryptococcus neoformans var. neoformans is a significant opportunistic fungal pathogen, particularly affecting immunocompromised individuals, including those with HIV/AIDS.
- Cryptococcal infections pose a life-threatening risk, with up to 13% of AIDS patients experiencing them during their disease course.
- Understanding the molecular basis of virulence in Cryptococcus neoformans serotype A is crucial for developing effective treatments.
Purpose of the Study:
- To identify Cryptococcus neoformans var. neoformans mutants with altered virulence using signature-tagged mutagenesis (STM).
- To explore the critical parameters of STM in Cryptococcus neoformans.
- To investigate the molecular basis of virulence in this fungal pathogen.
Main Methods:
- Signature-tagged mutagenesis (STM) was employed to generate and screen mutants.
- A competitive assay in a mouse model was used to assess altered growth and virulence.
- Molecular analyses, including Southern blotting and PCR, were performed to characterize the genetic modifications in identified mutants.
Main Results:
- STM successfully identified 39 mutants with significantly altered growth in competitive assays.
- Nearly half (49%) of the mutants had vector integration within the actin promoter, suggesting its role in virulence.
- Further analysis revealed five hypovirulent and one hypervirulent mutant upon individual challenge in a mouse model.
Conclusions:
- Signature-tagged mutagenesis is an effective tool for identifying virulence factors in Cryptococcus neoformans.
- Alterations in the actin promoter significantly impact the virulence of Cryptococcus neoformans.
- This research provides valuable insights into the genetic determinants of fungal pathogenicity, paving the way for novel therapeutic strategies.
